Discussions With Patients: Medical Marijuana

Poll

As our knowledge about herbal cannabis, the endocannabinoid system, and cannabinoid pharmacology expands, should psychiatrists discuss these issues with their patients?

OneLineMan/Shutterstock

Do you discuss medical marijuana/cannabis use for medical/psychiatric issues with your patients?

Yes
No
Related Videos
Somchaichoosiri/AdobeStock
Related Content
Here are highlights from the week in Psychiatric Times.

The Week in Review: April 15-19

April 20th 2024
Article
Here's to a Psychedelic Revolution

Here's to a Psychedelic Revolution

April 9th 2022
Podcast
From a look at record-high suicide rates to subspecialty shortages in psychiatry, here are highlights from the week in Psychiatric Times.

The Week in Review: April 8-12

April 13th 2024
Article
How to Talk to Teenagers About Substance Use

How to Talk to Teenagers About Substance Use

October 8th 2021
Podcast
From a groundbreaking FDA approval to the hidden toll of COVID-19, here are highlights from the week in Psychiatric Times.

The Week in Review: April 1-5

April 6th 2024
Article
This alters the course of developer Eisai's regulatory submission plans for lecanemab in the treatment of early Alzheimer disease.

FDA: Specific Fast Track Designation for Subcutaneous Formulation of Leqembi for Alzheimer Disease Needed for Rolling Review

April 3rd 2024
Article
© 2024 MJH Life Sciences

All rights reserved.